Literature DB >> 27238182

Comorbidities in lung cancer.

Agata Ewa Dutkowska1, Adam Antczak.   

Abstract

Comorbidity is the occurrence of concomitant disease in addition to an index disease of interest or the simultaneous occurrence of multiple diseases in an individual. Lung cancer is associated with age and smoking, and both age and smoking are strongly associated with comorbidity. Lung cancer is the most common malignancy in the world. Comorbidity, such as diseases of cardiovascular, pulmonary and other systems may influence prognosis in lung cancer as well as complicate its treatment. In this paper we tried to conclude the significance of the individual comorbidities in lung cancer and their impact on particular treatment method.

Entities:  

Keywords:  comorbidities; lung cancer

Mesh:

Year:  2016        PMID: 27238182     DOI: 10.5603/PiAP.2016.0022

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN: 0867-7077


  17 in total

Review 1.  Effect of inspiratory muscle training associated or not to physical rehabilitation in preoperative anatomic pulmonary resection: a systematic review and meta-analysis.

Authors:  Cindy de Oliveira Vacchi; Bianca Andrade Martha; Fabrício Edler Macagnan
Journal:  Support Care Cancer       Date:  2021-08-21       Impact factor: 3.359

2.  Survival score to characterize prognosis in inoperable stage III NSCLC after chemoradiotherapy.

Authors:  Julian Taugner; Lukas Käsmann; Chukwuka Eze; Maurice Dantes; Olarn Roengvoraphoj; Kathrin Gennen; Monika Karin; Oleg Petruknov; Amanda Tufman; Claus Belka; Farkhad Manapov
Journal:  Transl Lung Cancer Res       Date:  2019-10

3.  GTSE1 Facilitates the Malignant Phenotype of Lung Cancer Cells via Activating AKT/mTOR Signaling.

Authors:  Fan Zhang; Jingfei Meng; Hong Jiang; Xing Feng; Dongshan Wei; Wen Meng
Journal:  Anal Cell Pathol (Amst)       Date:  2021-05-01       Impact factor: 2.916

4.  Increased levels of long noncoding RNA LINC00691 correlate with poor prognosis in non-small-cell lung cancer patients.

Authors:  Yan Xie; Xiuhua Hu
Journal:  J Clin Lab Anal       Date:  2020-05-18       Impact factor: 2.352

Review 5.  Multifaceted Roles of Caveolin-1 in Lung Cancer: A New Investigation Focused on Tumor Occurrence, Development and Therapy.

Authors:  Yu-Bo Shi; Jun Li; Xing-Ning Lai; Rui Jiang; Rui-Chen Zhao; Li-Xia Xiong
Journal:  Cancers (Basel)       Date:  2020-01-25       Impact factor: 6.639

6.  Pretreatment nutritional status and response to checkpoint inhibitors in lung cancer.

Authors:  Chung-Shien Lee; Craig E Devoe; Xinhua Zhu; Joanna Stein Fishbein; Nagashree Seetharamu
Journal:  Lung Cancer Manag       Date:  2020-04-24

7.  The impact of symptoms and comorbidity on health utility scores and health-related quality of life in small cell lung cancer using real world data.

Authors:  Geoffrey Liu; Grainne M O'Kane; Ali Vedadi; Sharara Shakik; M Catherine Brown; Benjamin H Lok; Frances A Shepherd; Natasha B Leighl; Adrian Sacher; Penelope A Bradbury; Wei Xu
Journal:  Qual Life Res       Date:  2020-08-26       Impact factor: 3.440

8.  Factors related to and economic implications of inhospital death in German lung cancer patients - results of a Nationwide health insurance claims data based study.

Authors:  Karina Deckert; Julia Walter; Larissa Schwarzkopf
Journal:  BMC Health Serv Res       Date:  2018-10-19       Impact factor: 2.655

9.  [Lung cancer in Eastern Morocco: where do we stand?]

Authors:  Karam Yahya Belmokhtar; Mariam Tajir; Redouane Boulouiz; Amal Bennani; Sami Aziz Brahmi; Ihsan Alloubi; Hatim Kouismi; Imane Kamaoui; Imane Skiker; Said Afqir; Naima Abda; Mohammed Bellaoui; Loubna Mezouar
Journal:  Pan Afr Med J       Date:  2019-12-05

10.  Comorbidity in lung cancer patients and its association with medical service cost and treatment choice in China.

Authors:  Ruoxi Ding; Dawei Zhu; Ping He; Yong Ma; Zhishui Chen; Xuefeng Shi
Journal:  BMC Cancer       Date:  2020-03-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.